A bold theory suggests Vegeta could merge with Beerus without him dying, evolving into a new fusion type and the strongest ...

Dragon Ball is dense with dangerous villains, many of whom have multiple forms, some of which are more memorable than others.

The cover of Dragon Ball Super Vol. 24 has sent shockwaves through the fandom with one of the most exciting group shots in ...

NASDAQ MRUS opened at $47.09 on Friday. The stock has a fifty day simple moving average of $42.04 and a 200-day simple moving average of $46.77. Merus has a twelve month low of $37.77 and a twelve ...

Kourtnee covers TV streaming services and home entertainment news and reviews at CNET. She previously worked as an entertainment reporter at Showbiz Cheat Sheet where she wrote about film ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Iovance Biotherapeutics (IOVA – Research Report), Xencor (XNCR – Research Report) and Merus ...

In September 2024, Merus announced the first patient was dosed in LiGeR-HN1, a phase 3 trial evaluating the efficacy and safety of petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC ...

Merus B.V. earnings at a glance (GAAP) : -Earnings: -$215.33 Mln. vs. -$154.94 Mln. last year. -EPS: -$3.35 vs. -$3.00 last year. -Revenue: $36.13 Mln vs. $43.95 Mln last year. The views and ...

Merus N.V. announced progress on its clinical trials involving petosemtamab, designed for treating recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) and metastatic colorectal ...

TD Cowen 45th Annual Health Care Conference: Tuesday, March 4 at 9:10 a.m. ET Leerink Partners Global Healthcare Conference: Monday, March 10 at 11:20 a.m. ET The webcasts of the presentations will be ...

If you’re on the fence about investing in Vericel Corporation or Merus N.V. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.